Finance, Grants, Deals

Santhera Pharmaceuticals of Switzerland has raised a gross CHF 15.9 million in a private share placement with Ares Life Sciences, an investment vehicle controlled by the Bertarelli family.

Apitope International NV, a biopharmaceutical company based in Belgium, has raised €10 million in a series A financing to develop a peptide therapeutic for multiple sclerosis.

Nitec Pharma AG, a Swiss specialty pharmaceutical company, said it has obtained a CHF 24 million (€15.2 million) equity investment from five institutions to finance preparations for the approval and launch of Lodotra, its treatment for rheumatoid arthritis and other inflammatory diseases as well as the development of a product for pain.

GlaxoSmithKline has acquired at least 3% of Addex Pharmaceuticals Ltd through the purchase of shares on the open market.

BTG Plc has announced an all-share offer for Protherics Plc valued at £218.1 million, ending weeks of speculation about the fate of Protherics, a specialty pharmaceutical company.

Intercytex Group of the UK has raised £2.75 million before expenses through a placement of new shares with existing institutional shareholders. The money will be used to finance Phase 3 trials of its lead product for chronic wounds, cyzact.

Investors in SkyePharma Plc will experience a demonstration of the proposition that a slim cut of a big pie is better than a fat cut of a small one.

SpePharm Holding BV, the umbrella organisation for a Paris-based company that sells specialised drugs to hospitals in Europe, has raised €26 million with a combination of equity financing and the sale of future revenues from a spasticity drug whose European rights it recently acquired.

The recently restructured Medical Marketing International Group Plc (MMI) has raised gross proceeds of £0.95 million in an institutional share placement designed to fund its oncology programmes.

York Pharma Plc, a specialist dermatology company, has completed its previously- announced £3.9 million share placement which is part of a larger fundraising to finance the purchase of two wound-care products from Belgium‘s Solvay Pharmaceuticals BV.